Home Diagnostics, Inc. Wins Governor’s Export Excellence Award
September 15 2009 - 4:30PM
Business Wire
Home Diagnostics, Inc. (NASDAQ:HDIX), a leading developer,
manufacturer, and marketer of blood glucose monitoring systems,
today announced that the company has received a 2009 Governor’s
Export Excellence Award. The award, part of the 2009 Governor's
Business Diversification Awards program, recognizes Home
Diagnostics for its international growth and increase in export
sales, expansion of the company’s TRUEtest platform for diabetes
monitoring, and overall contributions to Florida’s economic
diversification and job creation.
Home Diagnostics won the award as a result of its strategic
expansion into Latin America and more than 80 percent of the
countries in Europe. Data suggests that Home Diagnostics has
increased its market share throughout Latin America, as well as in
the United Kingdom where it recently launched a new blood glucose
monitoring system called TRUEone. Continued international expansion
is a key strategic initiative for Home Diagnostics as it plans
expansions into Asia and Europe in 2010.
“Our team is honored to be recognized with the Governor’s Export
Excellence Award. We remain committed to supporting Florida’s
economy while delivering high-quality diabetes testing supplies to
people with diabetes across the globe,” said Joe Capper, president
and CEO of Home Diagnostics. “Home Diagnostics is proud to help
represent the best of the Sunshine State’s vibrant economy,
technological innovation and job creation.”
The Governor’s Business Diversification Awards are coordinated
by Enterprise Florida Inc., a public-private partnership serving as
Florida’s primary organization devoted to statewide economic
development. Enterprise Florida’s mission is to diversify the
state’s economy and create better-paying jobs for its citizens by
supporting, attracting and helping to create businesses in
innovative, high-growth industries.
The 2009 Governor’s Business Diversification Awards winners were
honored at a ceremony on Tuesday, September 15, 2009 in
Tallahassee, Florida.
About Home Diagnostics, Inc.
Based in Fort Lauderdale, Florida, Home Diagnostics, Inc.
(NASDAQ:HDIX) is a leading developer, manufacturer and marketer of
diabetes management products. Home Diagnostics, Inc. offers a
portfolio of high-quality blood glucose monitoring systems that
spans the spectrum of features and benefits to help every person
with diabetes better monitor and manage their disease. The Home
Diagnostics, Inc. product line includes TRUE2go™, TRUEresult®,
TRUEbalance™, TRUEtrack®, Sidekick®, TRUEread® and Prestige Smart
System® blood glucose monitoring systems. The products are
available in more than 45,000 pharmacies throughout the U.S. Home
Diagnostics is the exclusive co-brand supplier of blood glucose
monitoring systems for leading pharmacies including CVS, Rite Aid
and Walgreens, as well as distributors such as AmerisourceBergen,
Cardinal Health, McKesson, Invacare and Liberty Medical. Home
Diagnostics, Inc. was named one of Forbes magazine’s “200 Best
Small Companies” in 2008, and in 2009 received several recognitions
for the company’s TRUE2go blood glucose meter, including a Medical
Design Excellence Award (MDEA) and a Gold Award in the Medical/Test
Equipment category as part of appliance DESIGN Magazine’s 22nd
Annual Excellence in Design (EID) Awards Competition. For more
information please visit www.homediagnostics.com.
Forward-Looking
Statements
The above statements include forward-looking statements and are
subject to risks and uncertainties. Forward-looking statements give
the Company’s current expectations and projections relating to its
financial condition, results of operations, plans, objectives,
future performance and business. The statements can be identified
by the fact that they do not relate strictly to historical or
current facts. These statements may include words such as
“anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,”
“believe” and other words and terms of similar meaning in
connection with any discussion of the timing or nature of future
operating or financial performance or other events.
All statements other than statements of historical facts
included in this release that address activities, events or
developments that we expect, believe or anticipate will or may
occur in the future are forward-looking statements.
These forward-looking statements are largely based on our
expectations and beliefs concerning future events, which reflect
estimates and assumptions made by the Company’s management. These
estimates and assumptions reflect the Company’s best judgment based
on currently known market conditions and other factors relating to
the Company’s operations and business environment, all of which are
difficult to predict and many of which are beyond its control.
Although the Company believes its estimates and assumptions to
be reasonable, they are inherently uncertain and involve a number
of risks and uncertainties that are beyond the Company’s control.
In addition, management’s assumptions about future events may prove
to be inaccurate. Management cautions all readers that the
forward-looking statements contained in this release are not
guarantees of future performance, and the Company cannot assure any
reader that those statements will be realized or the
forward-looking events and circumstances will occur. Actual results
may differ materially from those anticipated or implied in the
forward-looking statements due to the factors listed in the “Risk
factors” and “Management’s discussion and analysis of financial
condition and results of operations” sections contained in its
filings with the Securities and Exchange Commission. All
forward-looking statements speak only as of the date of this
release. The Company does not intend to publicly update or revise
any forward-looking statements as a result of new information,
future events or otherwise, except as required by law. These
cautionary statements qualify all forward-looking statements
attributable to the Company or persons acting on its behalf.
TRUE2go, TRUEresult, TRUEtrack, TRUEbalance, Sidekick, TRUEread
and Prestige Smart System are trademarks of Home Diagnostics, Inc.
All other trademarks are property of their respective owners.
[HDIX-F]
Home Diagnostics (MM) (NASDAQ:HDIX)
Historical Stock Chart
From Sep 2024 to Oct 2024
Home Diagnostics (MM) (NASDAQ:HDIX)
Historical Stock Chart
From Oct 2023 to Oct 2024